-
- News
- Books
Featured Books
- smt007 Magazine
Latest Issues
Current IssueCounterfeit Concerns
The distribution of counterfeit parts has become much more sophisticated in the past decade, and there's no reason to believe that trend is going to be stopping any time soon. What might crop up in the near future?
Solder Printing
In this issue, we turn a discerning eye to solder paste printing. As apertures shrink, and the requirement for multiple thicknesses of paste on the same board becomes more commonplace, consistently and accurately applying paste becomes ever more challenging.
A Culture of Thriving
One cannot simply command thriving; it must be nurtured, developed, and encouraged. In this issue, we explore strategies to improve your working relationship model—both internally and externally. In this culture of thriving, your business will grow in the process.
- Articles
- Columns
Search Console
- Links
- Events
||| MENU - smt007 Magazine
NOTE Partners with CellMark to Manufacture Medtech Product
March 7, 2018 | NOTEEstimated reading time: Less than a minute
NOTE recently has entered an agreement with CellMark AB for the manufacture of a new medtech product, My+Care, a wristband that uses AI (artificial intelligence) to analyse and monitor user health. By capturing data, risks can be predicted, relatives and carers informed, thus preventing many injuries and accidents.
The contract has an estimated sales value of some SEK25 million in 2018. The scheduled production start is in the first quarter.
"Our medtech initiative remains successful. This is a great example of a complete solution, where, by bringing competence early in the process, we can support the customer so their product comes to market faster," said Per Ovrén, NOTE’s CEO and President.
"CellMark views NOTE as a long-term partner for developing and manufacturing medtech products, taking complete responsibility for testing, sourcing and manufacturing life-saving solutions, which fits CellMark's business model as a global platform for medtech entrepreneurs," responded Niclas Möttus-Olsson, President of CellMark Medical.
Suggested Items
ODMs Slow Stocking; 4Q24 MLCC Shipments Expected to Decline by 3.6%
10/08/2024 | TrendForceTrendForce’s latest findings show that recent economic data points to a steady cooling of inflation in the US market, prompting the Federal Reserve to cut interest rates by 50 basis points in September to prevent a potential economic slowdown or recession.
Real Time with... SMTA Guadalajara 2024: From Taiwan to Mexico: TRI's Expansion
09/26/2024 | Real Time with... SMTA GuadalajaraSpeaking with Nolan Johnson is Fernando Salomon, sales manager for Test Research, Inc., discussing TRI's increasing presence in Mexico, particularly in Guadalajara. Salomon explains that TRI recognizes the importance of the Mexican market and has invested in local offices and staff.
NOTE Signs an Agreement for a New Factory in Lund
09/16/2024 | NOTENOTE has signed an agreement with the property developer Wihlborgs to build a new factory for the operations in NOTE Lund. This will allow for the increasing demand in the coming years. The property will be rented over 15 years.
SMTA International Announces Keynote Speaker: Jairek Robbins
09/13/2024 | SMTAThe SMTA International Conference & Expo is proud to announce Jairek Robbins as a keynote speaker at this year's event. He will be presenting on Wednesday, October 23 from 9:00 AM to 10:00 AM.
NOTE Board Approves Share Buyback
08/30/2024 | NOTEThe Board of Directors of Note AB has resolved, pursuant to the authorisation granted by the Annual General Meeting on 18 April 2024, to acquire own shares on Nasdaq Stockholm.